Saskia Litière

RECIST 1.1—Update and clarification: From the RECIST committee

Lawrence H. Schwartz, Saskia Litière, Elisabeth G.E. de Vries et al. · European Journal of Cancer · 2016 · 1.8K citations

Public Policy, Recist 1.1—Update, Law +2

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

Ian Judson, Jaap Verweij, Hans Gelderblom et al. · The Lancet Oncology · 2014 · 1.1K citations · Full text

Metastatic Soft-tissue Sarcoma, Versus Intensified Doxorubicin, Oncology +7

Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

Saskia Litière, Gustavo Werutsky, Ian S. Fentiman et al. · The Lancet Oncology · 2012 · 543 citations

Surgical Oncology, Breast Oncology, Medicine +8

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial

Sylvie Bonvalot, Alessandro Gronchi, C. Le Péchoux et al. · The Lancet Oncology · 2020 · 446 citations · Full text

Surgical Oncology, Primary Retroperitoneal Sarcoma, Radiation Therapy +7

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Fátima Cardoso, John M.S. Bartlett, Leen Slaets et al. · Annals of Oncology · 2017 · 381 citations · Full text

Eortc 10085/Tbcrc/big/nabcg, Breast Oncology, Medicine +7